United Therapeutics Corp
XNAS:UTHR 4:00:00 PM EDT
| Market Cap (Intraday) | 18.79B |
| Current PE | 15.12 |
| Forward PE | 15.27 |
| 2yr Forward PE | 14.13 |
| 10-Day MA | $424.84 |
| 50-Day MA | $401.74 |
| 200-Day MA | $335.79 |
United Therapeutics Corp Stock, XNAS:UTHR
1000 Spring Street, Silver Spring, Maryland 20910
United States of America
Phone: +1.301.608.9292
Number of Employees: 1305
Description
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.